EDNRA and prostate cancer: In the present study we took a look at the GPCR-AAB situation in patients with prostate cancer where we found ETA-AAB as for patients with BPH/LUTS, but additionally GPCR-AAB directed against the α1-adrenergic receptor (α1-AAB).